Teva Shows Progress on Restructuring But Investors Want More - TheStreet
Teva CEO Rejects Netanyahu Plea to Salvage Jerusalem Plant - Bloomberg
A bottle of Teva Pharmaceutical Industries Ltd. Clonazepam medication... News Photo - Getty Images
Teva Sees Adderall Supply Delays Continuing for 2-3 Months (1)
Future Teva CEO Seeks to 'Formulate Clear Strategy' - YouTube
Teva flags supply constraints to ADHD drug Adderall as demand rises (NYSE: TEVA) | Seeking Alpha
Israeli pharmaceutical company donating millions of doses of potential coronavirus drug to the U.S.
Teva to Sell Record $5 Billion of Sustainability-Linked Bonds - BNN Bloomberg
Teva Pharma's Short Sellers Double Down as Legal Woes Drag On - Bloomberg
Teva Is Facing Adderall Supply Disruptions as Demand for ADHD Drug Soars - BNN Bloomberg
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis - ABC News
Teva looks to sell generics in China through joint venture with Guangzhou Pharma: Bloomberg | Fierce Pharma
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
The Difficulties of Cloning a CEO - Bloomberg
Teva Pharmaceuticals to Cut 25% of Jobs in Huge Reshaping - The New York Times
Teva shares jump in Tel Aviv after report of up to 10,000 job cuts | The Times of Israel
Teva (TEVA) Agrees to $225 Million Texas Opioid Settlement, AG Says - Bloomberg
Teva to Pay $85 Million Settlement in Oklahoma Opioid Case - Bloomberg
Teva Prepared to Fight Charges in Generics Probe If Talks Fail - Bloomberg
Actavis CEO: Teva-Mylan deal could be "value-destroying" - Globes
Teva's Credit Rating Cut to Junk by Fitch - Bloomberg
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
Teva Negotiating Sale of Remaining Women's Health Assets, Report Says | Ctech
Teva CEO Says Drugmaker Will Fight U.S. Price-Fixing Charges (2)
